These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 16924702)

  • 1. [Reactivity of a novel monoclonal antibody ZCH-7-2D3 on leukemia cells and its clinical significance].
    Guo L; Tang YM; Shen HQ; Qian BQ; Ning BT; Zhang HZ; Zhang Y
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2006 Jul; 35(4):390-3. PubMed ID: 16924702
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The application of 4-color fluorescence labeling antibodies and its significance in immunophenotyping for leukemia by flow cytometer].
    Liu YR; Yu H; Chang Y; Chen SS
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2002 Oct; 10(5):423-7. PubMed ID: 12513741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunophenotypic patterns of childhood acute leukemias in Indonesia.
    Supriyadi E; Widjajanto PH; Veerman AJ; Purwanto I; Nency YM; Gunawan S; Nafianti S; Purnomosari D; Intansari US; Westra G; Cloos J
    Asian Pac J Cancer Prev; 2011; 12(12):3381-7. PubMed ID: 22471485
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibody-producing human-human hybridomas. III. Derivation and characterization of two antibodies with specificity for human myeloid cells.
    Andreasen RB; Olsson L
    J Immunol; 1986 Aug; 137(3):1083-90. PubMed ID: 3459756
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of acute leukemia cells with mixed lineage leukemia (MLL) gene rearrangements by flow cytometry using monoclonal antibody 7.1.
    Wuchter C; Harbott J; Schoch C; Schnittger S; Borkhardt A; Karawajew L; Ratei R; Ruppert V; Haferlach T; Creutzig U; Dörken B; Ludwig WD
    Leukemia; 2000 Jul; 14(7):1232-8. PubMed ID: 10914547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Reactivity of a novel monoclonal antibody ZCH-2B8a on normal hematopoietic cells and malignant cell lines and its significance].
    Tang YM; Guo L; Yang SL; Shen HQ; Qian BQ; Zhang Y; Zhang HZ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Oct; 14(5):990-4. PubMed ID: 17096904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Biological properties and sensitivity to induction therapy of differentiated cells expressing atypical immunophenotype in acute leukemia of children].
    Pituch-Noworolska A
    Folia Med Cracov; 2001; 42(3):5-80. PubMed ID: 12353422
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of the inhibitory KIR ligand HLA-Bw4 and HLA-C expression levels in the recognition of leukemic cells by Natural Killer cells.
    Verheyden S; Ferrone S; Mulder A; Claas FH; Schots R; De Moerloose B; Benoit Y; Demanet C
    Cancer Immunol Immunother; 2009 Jun; 58(6):855-65. PubMed ID: 18841361
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [CD36 expression in leukemia cells checked with multi-parameter flow cytometry and its significance].
    Tang HR; Wang FC; Jiang YW; Fei X; Jiang Q; Xu WL; Lin J
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Feb; 15(1):29-34. PubMed ID: 17490515
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comprehensive flow cytometry phenotype in acute leukemia at diagnosis and at relapse.
    Li X; Du W; Liu W; Li X; Li H; Huang SA
    APMIS; 2010 May; 118(5):353-9. PubMed ID: 20477810
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Characteristic analysis of acute leukemia immunophenotyping in 180 cases by flow cytometry].
    Yao ZJ; Liao L; Dang YH; Zhang J; Tian Y; Feng K; Qi CY; Wang JF; Chen H
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2004 Feb; 12(1):83-5. PubMed ID: 14989776
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Significance of Frequencies, Compositions, and/or Antileukemic Activity of (DC-stimulated) Invariant NKT, NK and CIK Cells on the Outcome of Patients With AML, ALL and CLL.
    Boeck CL; Amberger DC; Doraneh-Gard F; Sutanto W; Guenther T; Schmohl J; Schuster F; Salih H; Babor F; Borkhardt A; Schmetzer H
    J Immunother; 2017; 40(6):224-248. PubMed ID: 28557814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytotoxicity Assessment and Apoptosis-related Gene Profiling of Antibody Treated Acute Myeloid Leukemia (AML) and Acute Lymphocytic Leukemia (ALL) Cancerous Cell Lines.
    Habibi-Anbouhi M; Kafi Z; Ghazizadeh L; Kharazi S; Behdani M; Faraji F; Shokrgozar MA
    Iran J Allergy Asthma Immunol; 2019 Oct; 18(6):679-687. PubMed ID: 32245312
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical study on prognosis of acute leukemia subtypes Ly + AML and My + ALL].
    Liu B; Li R; Wu HJ; Chen Y
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Apr; 15(2):421-4. PubMed ID: 17493361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Immunophenotyping of 106 adult patients with acute leukemia by flow cytometry].
    Xu B; Hu C; Miao XD; Wu YH; Yi ZS; Yang Y; Meng FY; Feng R; Liu QF; Liu XL; Zheng WY
    Di Yi Jun Yi Da Xue Xue Bao; 2003 Oct; 23(10):1043-6. PubMed ID: 14559689
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Immunophenotype characteristics and prognosis of acute leukemia patients with cross expressing lymphoid and myeloid lineage associated antigens].
    Jiang NG; Chen XM; Zhu HL; Zhong L; Zeng TT; Jia YQ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Dec; 18(6):1405-9. PubMed ID: 21176339
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The expression of CD19 in 210 cases of childhood acute leukemia and its significance].
    Chen YH; Tang YM; Shen HQ; Song H; Yang SL; Shi SW; Qian BQ; Xu WQ; Ning BT
    Zhonghua Er Ke Za Zhi; 2004 Mar; 42(3):188-91. PubMed ID: 15144712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activity of alemtuzumab in patients with CD52-positive acute leukemia.
    Tibes R; Keating MJ; Ferrajoli A; Wierda W; Ravandi F; Garcia-Manero G; O'Brien S; Cortes J; Verstovsek S; Browning ML; Faderl S
    Cancer; 2006 Jun; 106(12):2645-51. PubMed ID: 16688777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The features and significance of immunophenotyping in adult acute leukemia].
    Pei MF; Zhang GS; Xiao L
    Hunan Yi Ke Da Xue Xue Bao; 2000 Jun; 25(3):262-4. PubMed ID: 12212161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Variable expression of CD49d antigen in B cell chronic lymphocytic leukemia is related to disease stages.
    Eksioğlu-Demiralp E; Alpdoğan O; Aktan M; Firatli T; Oztürk A; Budak T; Bayik M; Akoğlu T
    Leukemia; 1996 Aug; 10(8):1331-9. PubMed ID: 8709639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.